What are the typical doses and administration guidelines for cardiac medications, including ACE (Angiotensin-Converting Enzyme) inhibitors, beta-blockers, aldosterone antagonists, antiarrhythmics, and antiplatelet agents, in the treatment of heart failure and myocardial infarction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cardiac Drug Dosing and Administration Guidelines

ACE Inhibitors

Start ACE inhibitors at low doses and titrate upward every 2 weeks to target doses proven in clinical trials, as higher doses significantly reduce hospitalizations and mortality in heart failure. 1

Specific Dosing Regimens

ACE Inhibitor Starting Dose Target Dose
Captopril 6.25 mg three times daily 50-100 mg three times daily [1]
Enalapril 2.5 mg twice daily 10-20 mg twice daily [1]
Lisinopril 2.5-5 mg once daily 30-35 mg once daily [1,2]
Ramipril 2.5 mg once daily 5 mg twice daily or 10 mg once daily [1]
Trandolapril 1 mg once daily 4 mg once daily [1]

Administration Protocol

  • Double the dose at minimum 2-week intervals until target dose is reached 1
  • Monitor blood pressure, renal function (creatinine, BUN), and potassium 1-2 weeks after each dose increase, at 3 months, then every 6 months 1, 3
  • Accept creatinine increases up to 50% above baseline or up to 3 mg/dL (266 μmol/L), whichever is greater 1
  • Potassium levels up to 5.5-6.0 mmol/L are acceptable 1

Critical Cautions - Seek Specialist Advice When:

  • Creatinine >2.5 mg/dL (>221 μmol/L) 1
  • Potassium >5.0 mmol/L 1
  • Systolic blood pressure <90 mmHg 1

Problem Management

For symptomatic hypotension: Reduce or eliminate nitrates, calcium channel blockers, and other vasodilators first; if no congestion present, reduce diuretic dose before adjusting ACE inhibitor 1

For persistent cough: Only discontinue if severe enough to prevent sleep and proven to recur after rechallenge; consider substituting an ARB, though angioedema can still occur 1

For rising creatinine/potassium: Stop NSAIDs, non-essential vasodilators, and potassium supplements; reduce diuretics if no congestion present 1


Beta-Blockers

Only three beta-blockers have proven mortality reduction in heart failure—bisoprolol, carvedilol, and metoprolol succinate extended-release—and benefits cannot be assumed as a class effect. 1

Evidence-Based Dosing

Beta-Blocker Starting Dose Target Dose Mean Dose in Trials
Bisoprolol 1.25 mg once daily 10 mg once daily 8.6 mg/day [1]
Carvedilol 3.125 mg twice daily 25-50 mg twice daily 37 mg/day [1]
Metoprolol succinate ER 12.5-25 mg once daily 200 mg once daily 159 mg/day [1]

Initiation Requirements

  • Patient must be relatively stable without IV inotropes or marked fluid retention 1
  • Should already be on ACE inhibitor therapy 1, 3
  • Double dose every 1-2 weeks if preceding dose tolerated 1
  • Monitor heart rate, blood pressure, clinical status, and body weight 1

Managing Adverse Effects

For worsening congestion (dyspnea, edema, weight gain >1.5-2 kg over 2 days): Double diuretic dose first; only halve beta-blocker dose if diuretic increase ineffective 1

For heart rate <50 bpm with symptoms: Halve beta-blocker dose; review other rate-slowing drugs (digoxin, amiodarone, diltiazem); obtain ECG to exclude heart block 1

For symptomatic hypotension: Reconsider need for nitrates and calcium channel blockers before adjusting beta-blocker 1


Aldosterone Antagonists

Aldosterone antagonists are indicated in NYHA class III-IV heart failure in addition to ACE inhibitors and diuretics to reduce mortality. 1

Dosing Regimens

Drug Starting Dose Target/Maximum Dose Mean Dose in Trials
Spironolactone 12.5-25 mg once daily 25 mg once or twice daily 26 mg/day [1]
Eplerenone 25 mg once daily 50 mg once daily 42.6 mg/day [1]

Monitoring Protocol

  • Check potassium and creatinine after 5-7 days, then recheck every 5-7 days until stable 1
  • Avoid initiating with potassium-sparing diuretics (amiloride, triamterene) during ACE inhibitor titration 1, 3
  • Use only if hypokalemia persists after ACE inhibitor and diuretic initiation 1

Angiotensin Receptor Blockers (ARBs)

ARBs are recommended as alternatives to ACE inhibitors in patients who are ACE inhibitor intolerant, particularly due to cough, to reduce morbidity and mortality. 1

Dosing for Heart Failure

ARB Starting Dose Target Dose Mean Dose in Trials
Candesartan 4-8 mg once daily 32 mg once daily 24 mg/day [1]
Losartan 25-50 mg once daily 50-150 mg once daily 129 mg/day [1]
Valsartan 20-40 mg twice daily 160 mg twice daily 254 mg/day [1]

Critical Warning

Exercise extreme caution when substituting ARBs in patients with ACE inhibitor-induced angioedema, as angioedema can also occur with ARBs. 1


Diuretics

Loop diuretics or thiazides should always be administered in addition to ACE inhibitors for symptomatic fluid overload. 1, 3

Loop Diuretics

Drug Starting Dose Maximum Daily Dose
Furosemide 20-40 mg 250-500 mg [1]
Bumetanide 0.5-1 mg 5-10 mg [1]
Torasemide 5-10 mg 100-200 mg [1]

Escalation Strategy for Insufficient Response

  1. Increase dose of current diuretic 1
  2. Combine loop diuretic with thiazide 1
  3. Administer loop diuretic twice daily for persistent fluid retention 1
  4. Add metolazone in severe heart failure with frequent creatinine and electrolyte monitoring 1

Renal Considerations

Do not use thiazides if GFR <30 mL/min, except synergistically with loop diuretics 1


Digoxin

The usual daily dose is 0.25-0.375 mg if creatinine is normal; reduce to 0.125-0.25 mg in elderly patients. 1

  • No loading dose needed for chronic conditions; can initiate with 0.25 mg twice daily for 2 days 1
  • Indicated for atrial fibrillation with any degree of symptomatic heart failure to slow ventricular rate 1
  • In sinus rhythm, improves clinical status in patients with persistent symptoms despite ACE inhibitor and diuretic treatment 1

Absolute Contraindications

Bradycardia, second- or third-degree AV block, sick sinus syndrome, carotid sinus syndrome, hypokalemia, hypercalcemia 1


Post-Myocardial Infarction Dosing

For hemodynamically stable patients within 24 hours of acute MI, initiate lisinopril 5 mg orally, followed by 5 mg at 24 hours, 10 mg at 48 hours, then 10 mg once daily for at least 6 weeks. 2

For low systolic BP (≤120 mmHg and >100 mmHg) during first 3 days: Start with 2.5 mg 2

If systolic BP ≤100 mmHg: Maintain 5 mg daily with temporary reductions to 2.5 mg if needed 2

If prolonged hypotension (systolic BP <90 mmHg for >1 hour): Withdraw lisinopril 2


Renal Dosing Adjustments

ACE Inhibitors (Lisinopril Example)

  • CrCl >30 mL/min: No adjustment needed 2
  • CrCl 10-30 mL/min: Reduce initial dose by 50% (e.g., hypertension 5 mg, heart failure 2.5 mg, acute MI 2.5 mg); titrate to maximum 40 mg daily 2
  • CrCl <10 mL/min or hemodialysis: Initial dose 2.5 mg once daily 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Heart Failure Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.